SCHEMBL4573371

SCHEMBL4573371

N#CC1(C2(C(N)=O)CCCCC2C(=O)N2CCC(c3cccnc3)C2)CC1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HSD11B1 P28845 5/20 0.48
▸ SPR P35270 1/20 0.43
▸ NAMPT P43490 1/20 0.40
▸ DPP4 P27487 1/20 0.39
▸ DPP8 Q6V1X1 1/20 0.39
▸ DPP9 Q86TI2 1/20 0.39
▸ RORC P51449 3/20 0.38
▸ CYP11B2 P19099 1/20 0.38
▸ CHRNB2 P17787 1/20 0.35
▸ CHRNA7 P36544 1/20 0.35
▸ CHRNA4 P43681 1/20 0.35
▸ PRMT5 O14744 1/20 0.35
▸ WDR77 Q9BQA1 1/20 0.35
▸ KDM4E B2RXH2 3/20 0.35
▸ BLM P54132 1/20 0.35
▸ ALOX15 P16050 1/20 0.35
▸ MEN1 O00255 2/20 0.34
▸ ALDH1A1 P00352 2/20 0.34
▸ KMT2A Q03164 2/20 0.34
▸ HPGD P15428 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4573111 0.83 USP30 (0.47) HSD11B1SPRNAMPTPRMT5WDR77
SCHEMBL14413519 0.74 HSD11B1 (0.60) HSD11B1SPRNAMPTDPP4DPP8
SCHEMBL4789865 0.73 KEAP1 (0.51) DPP4DPP8ALDH1A1HPGDTDP1
SCHEMBL8110155 0.72 CTSK (0.58) —
SCHEMBL4584329 0.72 HRH3 (0.40) —
SCHEMBL4789292 0.70 NAMPT (0.38) NAMPTALDH1A1
SCHEMBL3928801 0.70 HSD11B1 (0.60) HSD11B1SPRNAMPTRORCCYP11B2
SCHEMBL20149062 0.70 HSD11B1 (0.63) HSD11B1SPRNAMPTCYP11B2CHRNB2
SCHEMBL14276850 0.70 HSD11B1 (0.60) HSD11B1SPRNAMPTRORCCYP11B2
SCHEMBL29889680 0.69 HSD11B1 (0.56) HSD11B1SPRNAMPTDPP4DPP8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009001127-A1 CYANOCYCLOPROPYLCARBOXAMIDES AS CATHEPSIN INHIBITORS ASTRAZENECA AB (SE) 2008-12-31 — — WO disclosed
Send feedback